• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿血管瘤:一个与低体重儿出生率上升相关的新出现的健康问题。

Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants.

作者信息

Drolet Beth A, Swanson Elizabeth A, Frieden Ilona J

机构信息

Department of Dermatology and Pediatrics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.

出版信息

J Pediatr. 2008 Nov;153(5):712-5, 715.e1. doi: 10.1016/j.jpeds.2008.05.043.

DOI:10.1016/j.jpeds.2008.05.043
PMID:18940356
Abstract

A total of 420 children with infantile hemangioma (IH) were compared with 353 age-matched controls. Using multivariate logistic regression, low birth weight was the most significant risk factor; for every 500-g decrease in birth weight, the risk of IH increased by 40%. A positive family history also increased the risk of IH (33% vs 15% of controls; P < .001).

摘要

共有420例患有婴儿血管瘤(IH)的儿童与353例年龄匹配的对照组儿童进行了比较。通过多因素逻辑回归分析,低出生体重是最显著的风险因素;出生体重每降低500克,患IH的风险增加40%。阳性家族史也会增加患IH的风险(对照组为15%,有家族史者为33%;P <.001)。

相似文献

1
Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants.婴儿血管瘤:一个与低体重儿出生率上升相关的新出现的健康问题。
J Pediatr. 2008 Nov;153(5):712-5, 715.e1. doi: 10.1016/j.jpeds.2008.05.043.
2
Infantile hemangiomas and retinopathy of prematurity: possible association.婴儿血管瘤与早产儿视网膜病变:可能的关联。
Pediatrics. 2009 Mar;123(3):e484-9. doi: 10.1542/peds.2007-0803. Epub 2009 Feb 16.
3
Poor preventive care achievement and program retention among low birth weight infant Medicaid enrollees.低出生体重婴儿医疗补助计划参保者的预防性保健成效不佳且项目留存率低。
Pediatrics. 2006 Nov;118(5):e1509-15. doi: 10.1542/peds.2004-0489. Epub 2006 Oct 23.
4
Risk factors associated with low birth weight infants in the Malaysian population.马来西亚人群中与低体重儿相关的风险因素。
Med J Malaysia. 2008 Oct;63(4):306-10.
5
Perinatal risk factors and infantile autism.围产期危险因素与婴幼儿自闭症
Acta Psychiatr Scand. 2006 Oct;114(4):257-64. doi: 10.1111/j.1600-0447.2006.00805.x.
6
Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study.婴儿血管瘤的人口统计学和临床特征及危险因素:一项中国病例对照研究。
Arch Dermatol. 2011 Sep;147(9):1049-56. doi: 10.1001/archdermatol.2011.122. Epub 2011 May 16.
7
Perinatal risk factors for neuroblastoma.神经母细胞瘤的围产期危险因素。
Cancer Causes Control. 2009 Apr;20(3):289-301. doi: 10.1007/s10552-008-9243-5. Epub 2008 Oct 21.
8
Low birth weight as a risk factor for infant mortality in Egypt.
East Mediterr Health J. 2008 Sep-Oct;14(5):992-1002.
9
Pregnancy outcome after age 40 and risk of low birth weight.40岁之后的妊娠结局及低出生体重风险。
J Obstet Gynaecol. 2009 Jul;29(5):378-83. doi: 10.1080/01443610902929537.
10
Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder.患有妥瑞氏综合征和注意力缺陷多动障碍儿童的产前和围产期发病率。
J Dev Behav Pediatr. 2009 Apr;30(2):115-21. doi: 10.1097/DBP.0b013e31819e6a33.

引用本文的文献

1
Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: observational cohort study.口服普萘洛尔治疗儿童眼眶附件血管瘤的实际疗效和安全性:观察性队列研究
Front Ophthalmol (Lausanne). 2025 May 5;5:1493171. doi: 10.3389/fopht.2025.1493171. eCollection 2025.
2
Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas.用于治疗婴儿血管瘤的盐酸普萘洛尔制剂的最新进展
Drug Des Devel Ther. 2025 Feb 18;19:1163-1183. doi: 10.2147/DDDT.S496847. eCollection 2025.
3
Ayurvedic management of hemangiomatous ulcer: A case report.
血管瘤性溃疡的阿育吠陀疗法:一例报告。
J Ayurveda Integr Med. 2024 Sep-Oct;15(5):101056. doi: 10.1016/j.jaim.2024.101056. Epub 2024 Oct 15.
4
Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma.755纳米长脉冲翠绿宝石激光联合2%盐酸卡替洛尔滴眼液治疗较厚浅表型婴幼儿血管瘤的时机及疗效评估
Clin Cosmet Investig Dermatol. 2024 Sep 5;17:2009-2019. doi: 10.2147/CCID.S483141. eCollection 2024.
5
Infantile Hemangioma: A Cross-Sectional Observational Study.婴儿血管瘤:一项横断面观察性研究。
Life (Basel). 2023 Sep 4;13(9):1868. doi: 10.3390/life13091868.
6
[Infantile hemangioma : Clinical manifestation, treatment, and differential diagnoses].[婴儿血管瘤:临床表现、治疗及鉴别诊断]
Dermatologie (Heidelb). 2023 May;74(5):331-339. doi: 10.1007/s00105-023-05145-2.
7
Management of infantile hemangiomas: Recent advances.婴儿血管瘤的管理:最新进展
Front Oncol. 2022 Nov 29;12:1064048. doi: 10.3389/fonc.2022.1064048. eCollection 2022.
8
Identification of Diagnostic Markers in Infantile Hemangiomas.婴儿血管瘤诊断标志物的鉴定
J Oncol. 2022 Dec 1;2022:9395876. doi: 10.1155/2022/9395876. eCollection 2022.
9
Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients.噻吗洛尔局部用药治疗婴幼儿血管瘤的良好临床反应者:一项对328例韩国患者的7年回顾性研究
Ann Dermatol. 2022 Oct;34(5):360-369. doi: 10.5021/ad.21.203.
10
Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size.婴儿血管瘤的母婴及围产期危险因素:一项大样本匹配病例对照研究
Dermatol Ther (Heidelb). 2022 Jul;12(7):1659-1670. doi: 10.1007/s13555-022-00756-4. Epub 2022 Jun 25.